Weaver C. Barksdale & Associates’s Bio-Techne TECH Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$3K	Sell	96 -4	-4%	-$127	﹤0.01%	429
2017 Q3	$3K	Sell	100 -16	-14%	-$475	﹤0.01%	430
2017 Q2	$3K	Hold	116	–	–	﹤0.01%	446
2017 Q1	$3K	Hold	116	–	–	﹤0.01%	457
2016 Q4	$3K	Buy	116 +20	+21%	+$525	﹤0.01%	452
2016 Q3	$3K	Hold	96	–	–	0.01%	446
2016 Q2	$3K	Hold	96	–	–	0.01%	436
2016 Q1	$2K	Hold	96	–	–	﹤0.01%	493
2015 Q4	$2K	Buy	96 +20	+26%	+$456	﹤0.01%	487
2015 Q3	$2K	Hold	76	–	–	﹤0.01%	487
2015 Q2	$2K	Hold	76	–	–	﹤0.01%	497
2015 Q1	$2K	Hold	76	–	–	﹤0.01%	502
2014 Q4	$2K	Hold	76	–	–	﹤0.01%	497
2014 Q3	$2K	Hold	76	–	–	﹤0.01%	494
2014 Q2	$2K	Hold	76	–	–	﹤0.01%	502
2014 Q1	$2K	Hold	76	–	–	﹤0.01%	511
2013 Q4	$2K	Hold	76	–	–	﹤0.01%	509
2013 Q3	$2K	Hold	76	–	–	﹤0.01%	516
2013 Q2	$1K	Buy	+76	New	+$1.26K	﹤0.01%	540

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Weaver C. Barksdale & Associates's TECH Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its Bio-Techne (TECH) stake by 4% in Q4 2017, selling an estimated $127 and leaving 96 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #429.

Weaver C. Barksdale & Associates first reported a position in TECH in Q2 2013 and has held it in 19 quarters since. 297 funds tracked by Wall St. Rank hold TECH as of Q4 2017.

Weaver C. Barksdale & Associates held 96 shares of Bio-Techne worth $3K as of Q4 2017.
Weaver C. Barksdale & Associates sold 4 Bio-Techne shares in Q4 2017, an estimated $127.
Bio-Techne made up ﹤0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #429 holding.
Weaver C. Barksdale & Associates first reported a position in Bio-Techne in Q2 2013 and has held it in 19 quarters since.
297 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.